Australian Broker Call *Extra* Edition – Sep 16, 2024

This story features AURA ENERGY LIMITED, and other companies. For more info SHARE ANALYSIS: AEE

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

AEE   ANZ   AX1   BXB   CBA   CCR   CU6   DXB   HGO   MAY   NAB   NWC   REG   WBC  

AEE    AURA ENERGY LIMITED

Energy – Overnight Price: $0.13

Petra Capital rates ((AEE)) as Buy (1) –

Petra Capital lowers its target for Aura Energy to 33c from 40c after revising the assumed future equity raise price, despite forecasting additional mine life for the Tiris uranium project in Mauritania.

The broker expects a final investment decision (FID) in the March quarter of 2025.

The September FEED study increases the analyst’s Tiris net present value (NPV) by 29% to US$499m by extending the assumed base case life-of-mine (LOM) to 25 years from 17 years, and subsequently LOM production by 44%.

This report was published on September 12, 2024.

Target price is $0.33 Current Price is $0.13 Difference: $0.2
If AEE meets the Petra Capital target it will return approximately 154% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 43.33.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 32.50.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ANZ    ANZ GROUP HOLDINGS LIMITED

Banks – Overnight Price: $31.15

Jarden rates ((ANZ)) as Neutral (3) –

Jarden’s new order of preference among the major Australian banks is National Australia Bank (Overweight), Westpac and ANZ Bank with Neutral ratings, followed by the Underweight-rated CommBank.

Overall, the broker expects resilient near-term bank earnings and continues to see upside risks to FY25 consensus forecasts, driven by slightly better margins and currently overstated loan loss expectations.

The analysts raise FY25 and FY26 EPS forecasts by around 1-2% across the majors, while 12-month target prices rise modestly.

The target for ANZ Bank rises to $30 from $29.50.

This report was published on September 16, 2024.

Target price is $30.00 Current Price is $31.15 Difference: minus $1.15 (current price is over target).
If ANZ meets the Jarden target it will return approximately minus 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $27.37, suggesting downside of -12.8%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 167.00 cents and EPS of 230.00 cents.
At the last closing share price the estimated dividend yield is 5.36%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.54.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 224.0, implying annual growth of -5.4%.
Current consensus DPS estimate is 164.8, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 14.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 168.00 cents and EPS of 236.00 cents.
At the last closing share price the estimated dividend yield is 5.39%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.20.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 219.9, implying annual growth of -1.8%.
Current consensus DPS estimate is 166.8, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 14.3.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AX1    ACCENT GROUP LIMITED

Apparel & Footwear – Overnight Price: $2.25

Wilsons rates ((AX1)) as Overweight (1) –

Post a field trip, Wilsons is more positive on the strategy to buy out Athletes Foot franchisees as the agreements come up for renewal for Accent Group.

The analyst also points to the strong brand growth in Hoka and believes the company will continue to benefit from the Vertical product which has grown 48% over the last three years (compound rate).

Overweight rating with a $2.55 target price.

This report was published on September 12, 2024.

Target price is $2.55 Current Price is $2.25 Difference: $0.3
If AX1 meets the Wilsons target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $2.48, suggesting upside of 11.4%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 12.00 cents and EPS of 14.90 cents.
At the last closing share price the estimated dividend yield is 5.33%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.10.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.2, implying annual growth of 33.8%.
Current consensus DPS estimate is 12.6, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 15.7.

Forecast for FY26:

Wilsons forecasts a full year FY26 dividend of 15.40 cents and EPS of 19.20 cents.
At the last closing share price the estimated dividend yield is 6.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.72.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.4, implying annual growth of 15.5%.
Current consensus DPS estimate is 14.6, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 13.6.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BXB    BRAMBLES LIMITED

Transportation & Logistics – Overnight Price: $18.33

Jarden rates ((BXB)) as Overweight (2) –

Jarden highlights key takeaways from the Brambles’ Strategy Day.

The broker notes management gave some good insights into the near-term strategic direction of the company as it focuses on asset efficiency, improved asset tracking and productivity.

Jarden believes investors will concentrate on cashflow generation of over US$750m forecast between FY26-FY26 considering capex commitments from both pooling and non-pooling as well as improved operating efficiencies to increase margins.

Overweight rating and $17.90 target price unchanged. No changes to earnings forecasts.

This report was published on September 12, 2024.

Target price is $17.90 Current Price is $18.33 Difference: minus $0.43 (current price is over target).
If BXB meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $18.76, suggesting upside of 0.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 84.49 cents and EPS of 93.60 cents.
At the last closing share price the estimated dividend yield is 4.61%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 93.0, implying annual growth of N/A.
Current consensus DPS estimate is 58.4, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 20.0.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 91.78 cents and EPS of 101.81 cents.
At the last closing share price the estimated dividend yield is 5.01%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 105.2, implying annual growth of 13.1%.
Current consensus DPS estimate is 66.4, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 17.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CBA    COMMONWEALTH BANK OF AUSTRALIA

Banks – Overnight Price: $141.65

Jarden rates ((CBA)) as Underweight (4) –

Jarden’s new order of preference among the major Australian banks is National Australia Bank (Overweight), Westpac and ANZ Bank with Neutral ratings, followed by the Underweight-rated CommBank.

Overall, the broker expects resilient near-term bank earnings and continues to see upside risks to FY25 consensus forecasts, driven by slightly better margins and currently overstated loan loss expectations.

The analysts raise FY25 and FY26 EPS forecasts by around 1-2% across the majors, while 12-month target prices rise modestly.

The target for CommBank rises to $107 from $106.

This report was published on September 16, 2024.

Target price is $107.00 Current Price is $141.65 Difference: minus $34.65 (current price is over target).
If CBA meets the Jarden target it will return approximately minus 24% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $99.48, suggesting downside of -30.4%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 472.00 cents and EPS of 595.00 cents.
At the last closing share price the estimated dividend yield is 3.33%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.81.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 593.8, implying annual growth of 4.7%.
Current consensus DPS estimate is 475.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 24.1.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 480.00 cents and EPS of 611.00 cents.
At the last closing share price the estimated dividend yield is 3.39%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 611.4, implying annual growth of 3.0%.
Current consensus DPS estimate is 488.3, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 23.4.

Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CCR    CREDIT CLEAR LIMITED

Diversified Financials – Overnight Price: $0.29

Petra Capital rates ((CCR)) as Buy (1) –

Petra Capital continues to advocate for a contrarian play on Credit Clear despite clear evidence of a deteriorating macro-economic environment, including hardship cases highlighted by Origin Energy ((ORG)) and rising business insolvencies.

The company is continuing to growth its Tier-1 clients up 67% in FY24 which infers improved revenue growth in around 12-15 months given the lag, the analyst notes.

The target price lifts to 53c from 51c. Buy rating unchanged.

This report was published on September 13, 2024.

Target price is $0.53 Current Price is $0.29 Difference: $0.24
If CCR meets the Petra Capital target it will return approximately 83% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 290.00.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.22.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CU6    CLARITY PHARMACEUTICALS LIMITED

Medical Equipment & Devices – Overnight Price: $7.58

Wilsons rates ((CU6)) as Overweight (1) –

Wilsons observes the latest announcement from Clarity Pharmaceuticals providing further progress of the company’s development in its prostate cancer therapy program.

The company reported positive data from cohort 4 of the phase 1/11 SECuRE trial. The analyst also notes further information is expected on September 18 on the company’s call/webcast.

The Overweight rating is maintained. No changes are made to the broker’s earnings forecasts.

This report was published on September 12, 2024.

Target price is $8.48 Current Price is $7.58 Difference: $0.9
If CU6 meets the Wilsons target it will return approximately 12% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 13.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 56.57.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 17.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 44.33.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

DXB    DIMERIX LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.42

Petra Capital rates ((DXB)) as Buy (1) –

The first patient has completed the FSGS registrational trial, notes Petra Capital, and management is simultaneously focusing on out-licensing regional rights for the drug.

FSGS stands for Focal Segmental Glomerulosclerosis (FSGS), a rare and serious kidney disease.

The company remains funded through to key second interim results from the trial, assures the broker, with $22.1m of cash and expected near term cash inflows of circa $16.2m.

The Buy rating and $1.33 target remain.

This report was published on September 12, 2024.

Target price is $1.33 Current Price is $0.42 Difference: $0.91
If DXB meets the Petra Capital target it will return approximately 217% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.26.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 1.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.71.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

HGO    HILLGROVE RESOURCES LIMITED

Copper – Overnight Price: $0.05

Moelis rates ((HGO)) as Initiation of coverage with Buy (1) –

Moelis initiates coverage on copper producer Hillgrove Resources with a Buy rating and 8c target after the recent re-start of the Kanmantoo underground mine in South Australia. A positive resource and reserve update is expected in the December quarter this year.

The stock price stock is “acutely” leveraged to both copper price and further exploration upside given the extensive infrastructure already installed, suggests the analyst.

The broker expects the mine to produce approximately 11-12kt of copper annually and sees potential for further exploration upside to either incrementally or more substantially raise the mine life beyond four years.

In explaining risk/reward asymmetry for Hillgrove, Moelis highlights the lack of any significant financial obligations, and the broker’s expectations for operational delivery and valuation upside.

This report was published on September 16, 2024.

Target price is $0.08 Current Price is $0.05 Difference: $0.03
If HGO meets the Moelis target it will return approximately 60% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.00.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 3.85.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

MAY    MELBANA ENERGY LIMITED

Crude Oil – Overnight Price: $0.03

Petra Capital rates ((MAY)) as Buy (1) –

Melbana Energy’s Amistad field development in Cuba has been approved by the joint venture and by the Cuban regulators. The development comprises the Alameda-2 well and two new shallow wells to be drilled in early-2025, observes Petra Capital.

Alameda-2 will re-commence production in November. When this is combined with existing inventories, the broker explains a small maiden shipment will occur by the end of 2024 to iron out logistics.

No change in target price of 8c or Buy rating.

This report was published on September 12, 2024.

Target price is $0.08 Current Price is $0.03 Difference: $0.05
If MAY meets the Petra Capital target it will return approximately 167% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.00 cents.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 15.00.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NAB    NATIONAL AUSTRALIA BANK LIMITED

Banks – Overnight Price: $38.28

Jarden rates ((NAB)) as Overweight (2) –

Jarden’s new order of preference among the major Australian banks is National Australia Bank (Overweight), Westpac and ANZ Bank with Neutral ratings, followed by the Underweight-rated CommBank.

Overall, the broker expects resilient near-term bank earnings and continues to see upside risks to FY25 consensus forecasts, driven by slightly better margins and currently overstated loan loss expectations.

The analysts raise FY25 and FY26 EPS forecasts by around 1-2% across the majors, while 12-month target prices rise modestly.

For National Australia Bank, the target rises to $37 from $36.

This report was published on September 16, 2024.

Target price is $37.00 Current Price is $38.28 Difference: minus $1.28 (current price is over target).
If NAB meets the Jarden target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $31.80, suggesting downside of -17.5%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 169.00 cents and EPS of 224.00 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 226.2, implying annual growth of -4.3%.
Current consensus DPS estimate is 167.7, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 17.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 169.00 cents and EPS of 233.00 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 231.8, implying annual growth of 2.5%.
Current consensus DPS estimate is 170.5, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 16.6.

Market Sentiment: -0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NWC    NEW WORLD RESOURCES LIMITED

Copper – Overnight Price: $0.02

Petra Capital rates ((NWC)) as Buy (1) –

Petra Capital highlights the approval process for the Antler Copper project in Arizona has taken longer than expected.

The latest application for the Air Quality Control permit was lodged recently and precedes several other permit applications which are anticipated to be filed in the coming weeks.

Buy and 10c target retained. No changes to EPS forecasts.

This report was published on September 12, 2024.

Target price is $0.10 Current Price is $0.02 Difference: $0.08
If NWC meets the Petra Capital target it will return approximately 400% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 20.00.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 20.00.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

REG    REGIS HEALTHCARE LIMITED

Aged Care & Seniors – Overnight Price: $5.75

Jarden rates ((REG)) as Overweight (2) –

Jarden notes the Federal Government’s Aged Care reform will take two and a half years to have a full financial impact on companies like Regis Healthcare.

The analyst estimates $27.5m in additional income per annum for the company which will be forthcoming in FY28/FY29 or an 18% rise to EBITDA over this period compared to current forecasts.

There are no changes to the broker’s earnings forecasts.

Overweight rating and $4.46 target price remain.

This report was published on September 12, 2024.

Target price is $4.46 Current Price is $5.75 Difference: minus $1.29 (current price is over target).
If REG meets the Jarden target it will return approximately minus 22% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company’s fiscal year ends in June.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 19.60 cents.
At the last closing share price the estimated dividend yield is 0.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.34.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 6.00 cents and EPS of 22.40 cents.
At the last closing share price the estimated dividend yield is 1.04%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.67.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WBC    WESTPAC BANKING CORPORATION

Banks – Overnight Price: $32.10

Jarden rates ((WBC)) as Downgrade to Neutral from Overweight (3) –

Jarden’s new order of preference among the major Australian banks is National Australia Bank (Overweight), Westpac and ANZ Bank with Neutral ratings, followed by the Underweight-rated CommBank.

Overall, the broker expects resilient near-term bank earnings and continues to see upside risks to FY25 consensus forecasts, driven by slightly better margins and currently overstated loan loss expectations.

The analysts raise FY25 and FY26 EPS forecasts by around 1-2% across the majors, while 12-month target prices rise modestly.

The target for Westpac rises to $29.20 from $28.60 and the rating is downgraded to Neutral from Overweight on an elevated relative valuation, explains the broker.

This report was published on September 16, 2024.

Target price is $29.20 Current Price is $32.10 Difference: minus $2.9 (current price is over target).
If WBC meets the Jarden target it will return approximately minus 9% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $26.73, suggesting downside of -17.9%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 182.00 cents and EPS of 193.00 cents.
At the last closing share price the estimated dividend yield is 5.67%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 191.9, implying annual growth of -6.5%.
Current consensus DPS estimate is 165.8, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 17.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 168.00 cents and EPS of 194.00 cents.
At the last closing share price the estimated dividend yield is 5.23%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 195.8, implying annual growth of 2.0%.
Current consensus DPS estimate is 157.3, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 16.6.

Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms